Literature DB >> 15385273

Avoidance hierarchies and preferences for anticoagulation--semi-qualitative analysis of older patients' views about stroke prevention and the use of warfarin.

Richard Fuller1, Nigel Dudley, Jon Blacktop.   

Abstract

OBJECTIVE: To examine older patients' preferences regarding the use of warfarin to prevent atrial fibrillation related strokes when faced with cumulative probabilities of treatment risk and benefit.
DESIGN: A semi-qualitative researcher administered questionnaire and interview.
SUBJECTS: 81 patients attending a general elderly medicine outpatient clinic.
RESULTS: Up to 50% of participants would decline warfarin treatment when shown both cumulative benefits of stroke risk reduction and risk of intracerebral haemorrhage. Principal themes highlighted concepts of gambling and trade offs relating to risk and benefit. Attitudes about stroke and negative perceptions of intracerebral haemorrhage were major contributory themes in the decision to refuse warfarin treatment.
CONCLUSION: Older people use very individualistic health beliefs in judging how to trade risks to preserve quality of life. Carefully explaining risk information and listening to elders' views and reasoning is likely to result in a more informed choice regarding the use of anticoagulation in stroke prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385273     DOI: 10.1093/ageing/afh202

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  26 in total

Review 1.  Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.

Authors:  Ekta Y Pandya; Beata Bajorek
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

Review 2.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Samantha MacLean; Sohail Mulla; Elie A Akl; Milosz Jankowski; Per Olav Vandvik; Shanil Ebrahim; Shelley McLeod; Neera Bhatnagar; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  How well do guidelines incorporate evidence on patient preferences?

Authors:  Christopher A K Y Chong; Ing-je Chen; Gary Naglie; Murray D Krahn
Journal:  J Gen Intern Med       Date:  2009-04-23       Impact factor: 5.128

4.  Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation.

Authors:  M Savage; M Teeling; K Bennett; J Feely
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

5.  Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?

Authors:  R Fuller; N J Dudley
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

6.  Patient preferences regarding atrial fibrillation stroke prophylaxis in patients at potential risk of atrial fibrillation.

Authors:  Nicholas T Edwards; Erica D Greanya; Peter S Loewen; Celia L Culley
Journal:  Int J Clin Pharm       Date:  2017-03-09

Review 7.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.

Authors:  Danielle E Clarkesmith; Helen M Pattison; Phyo H Khaing; Deirdre A Lane
Journal:  Cochrane Database Syst Rev       Date:  2017-04-05

8.  Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives.

Authors:  Pablo Alonso-Coello; Victor M Montori; M Gloria Díaz; Philip J Devereaux; Gemma Mas; Ana I Diez; Ivan Solà; Mercè Roura; Juan C Souto; Sven Oliver; Rafael Ruiz; Blanca Coll-Vinent; Ignasi Gich; Holger J Schünemann; Gordon Guyatt
Journal:  Health Expect       Date:  2014-05-12       Impact factor: 3.377

9.  TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).

Authors:  Danielle E Smith; Christian Borg Xuereb; Helen M Pattison; Gregory Y H Lip; Deirdre A Lane
Journal:  BMC Cardiovasc Disord       Date:  2010-05-20       Impact factor: 2.298

10.  Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.

Authors:  Yishen Wang; Beata Bajorek
Journal:  Int J Clin Pharm       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.